Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2013

01-08-2013 | Original Article

The involvement of Notch signaling in melanoma vasculogenic mimicry

Authors: Amalia Vartanian, Galina Gatsina, Irina Grigorieva, Elico Solomko, Vladislav Dombrovsky, Anatoly Baryshnikov, Eugenia Stepanova

Published in: Clinical and Experimental Medicine | Issue 3/2013

Login to get access

Abstract

Notch signaling plays an important role in tumor angiogenesis. Recent studies suggest that Notch signaling also regulates the progression of primary melanomas toward an aggressive phenotype. The aim of this study was to investigate the involvement of Notch signaling pathway in organization of tumor cells into capillary-like structures (CLS), the phenomenon also known as vasculogenic mimicry (VM). Here, we show that Notch signaling cascade was constitutively active in melanoma cell lines we used. Blocking Notch signaling with the γ-secretase inhibitors, DAPT, dibenzazepine or Jagged1 neutralizing antibody resulted in stabilization of CLS indicating that Notch signaling pathway attenuates melanoma VM. We further studied this phenomenon on melanomas grafted in nude mice. Compared to control, VM channels in DAPT-treated grafted melanoma became larger and more branched. DAPT-treated melanomas also exhibited an up-regulation of MMP-2 and VEGFR1, both known as VM mediators. Moreover, we did not observe necrosis in VM channels areas of DAPT-treated melanomas. These findings indicate that VM regulated by Notch signaling may present a novel target in melanoma therapy.
Literature
1.
go back to reference Feige JJ (2010) Tumour angiogenesis: recent progress and remaining challenges. Bull Cancer 97(11):1305–1310PubMed Feige JJ (2010) Tumour angiogenesis: recent progress and remaining challenges. Bull Cancer 97(11):1305–1310PubMed
2.
go back to reference Hiratsuka S (2011) Vasculogenesis, angiogenesis and special features of tumour blood vessels. Front Biosci 16:803–814CrossRef Hiratsuka S (2011) Vasculogenesis, angiogenesis and special features of tumour blood vessels. Front Biosci 16:803–814CrossRef
3.
go back to reference Quesada AR, Medina MA, Munoz-Chapuli R, Ronce AL (2010) Do not say ever never more: the ins and outs of antiangiogenic therapies. Curr Pharm Des 16(35):3932–3957PubMedCrossRef Quesada AR, Medina MA, Munoz-Chapuli R, Ronce AL (2010) Do not say ever never more: the ins and outs of antiangiogenic therapies. Curr Pharm Des 16(35):3932–3957PubMedCrossRef
4.
go back to reference Sharma PS, Sharma R, Tyagi T (2011) VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and Future. Curr Cancer Drug Targets 11(5):624–633PubMedCrossRef Sharma PS, Sharma R, Tyagi T (2011) VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and Future. Curr Cancer Drug Targets 11(5):624–633PubMedCrossRef
5.
go back to reference Gerger A, LaBonte M, Lenz HL (2011) Molecular predictors of response to antiangiogenesis therapies. Cancer J 17(2):134–141PubMedCrossRef Gerger A, LaBonte M, Lenz HL (2011) Molecular predictors of response to antiangiogenesis therapies. Cancer J 17(2):134–141PubMedCrossRef
6.
go back to reference Fan YZ, Sun W (2010) Molecular regulation of vasculogenic mimicry in tumours and potential tumor-target therapy. World J Gastrointest Surg 2(4):117–124PubMedCrossRef Fan YZ, Sun W (2010) Molecular regulation of vasculogenic mimicry in tumours and potential tumor-target therapy. World J Gastrointest Surg 2(4):117–124PubMedCrossRef
7.
go back to reference Paulis YW, Soetekouw PM, Verheul HM (2010) Signaling pathways in vasculogenic mimicry. Biochem Biophys Acta 1806(1):18–28PubMed Paulis YW, Soetekouw PM, Verheul HM (2010) Signaling pathways in vasculogenic mimicry. Biochem Biophys Acta 1806(1):18–28PubMed
8.
go back to reference Schwanbeck R, Martini S, Bernoth K, Just U (2011) The Notch signalling pathway: molecular basis of cell content dependency. Eur J Cell Biol 90(6–7):572–581PubMedCrossRef Schwanbeck R, Martini S, Bernoth K, Just U (2011) The Notch signalling pathway: molecular basis of cell content dependency. Eur J Cell Biol 90(6–7):572–581PubMedCrossRef
9.
go back to reference Eiken HM, Adams RM (2010) Dynamics of endothelial cell behaviour in sprouting angiogenesis. Curr Opin Cell Biol 22(5):617–625CrossRef Eiken HM, Adams RM (2010) Dynamics of endothelial cell behaviour in sprouting angiogenesis. Curr Opin Cell Biol 22(5):617–625CrossRef
10.
go back to reference Koch U, Radtke F (2010) Notch signaling in solid tumor. Curr Top Dev Biol 92:367–409CrossRef Koch U, Radtke F (2010) Notch signaling in solid tumor. Curr Top Dev Biol 92:367–409CrossRef
11.
go back to reference Guo S, Liu M, Gouzalez-Perez RR (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochem Biophys Acta 1815(2):197–213PubMed Guo S, Liu M, Gouzalez-Perez RR (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochem Biophys Acta 1815(2):197–213PubMed
12.
go back to reference Aster JC, Blacklow SC, Pear WS (2011) Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 223(2):262–273PubMedCrossRef Aster JC, Blacklow SC, Pear WS (2011) Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 223(2):262–273PubMedCrossRef
13.
go back to reference Sjolund J, Johanson M, Manna S, Norin C, Pietras A, Beckman S et al (2008) Suppression of renal cell carcinoma growth by inhibition of Notch signalling in vitro and in vivo. J Clin Invest 118(1):217–228PubMedCrossRef Sjolund J, Johanson M, Manna S, Norin C, Pietras A, Beckman S et al (2008) Suppression of renal cell carcinoma growth by inhibition of Notch signalling in vitro and in vivo. J Clin Invest 118(1):217–228PubMedCrossRef
14.
go back to reference Massi D, Tarantini F, Franchi A, Paglierani M, Serio Di, Pellerito S et al (2006) Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Modern Pathol 19:246–254CrossRef Massi D, Tarantini F, Franchi A, Paglierani M, Serio Di, Pellerito S et al (2006) Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Modern Pathol 19:246–254CrossRef
15.
go back to reference Jabobsson L, Bentley K, Gerhardt U (2009) VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem Soc Trans 37(6):216–233 Jabobsson L, Bentley K, Gerhardt U (2009) VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem Soc Trans 37(6):216–233
16.
go back to reference Cristofaro B, Emanueli C (2009) Possible novel targets for theraupetic angiogenesis. Curr Opin Pharmacol 9(2):102–108PubMedCrossRef Cristofaro B, Emanueli C (2009) Possible novel targets for theraupetic angiogenesis. Curr Opin Pharmacol 9(2):102–108PubMedCrossRef
17.
go back to reference Mikhailova IN, Lukashina MI, Baryshnikov AYu, Morozova LF, Kiselev CL, Georgiev GP (2005) Melanoma cell lines as the basis for antitumor vaccine preparation. Vest Ross Akad Med Nauk 7:37–40 Mikhailova IN, Lukashina MI, Baryshnikov AYu, Morozova LF, Kiselev CL, Georgiev GP (2005) Melanoma cell lines as the basis for antitumor vaccine preparation. Vest Ross Akad Med Nauk 7:37–40
18.
go back to reference Mikhailova IN, Kovalevsky DA, Morozova LF, Burova OS, Baryshnikov AYu, Bibilashvili RS (2008) Cancer/testis genes expression in human melanoma cell lines. Mel Res 18(5):303–313CrossRef Mikhailova IN, Kovalevsky DA, Morozova LF, Burova OS, Baryshnikov AYu, Bibilashvili RS (2008) Cancer/testis genes expression in human melanoma cell lines. Mel Res 18(5):303–313CrossRef
19.
go back to reference Vartanian A, Burova O, Stepanova E, Baryshnikov AYu, Lichinitser MR (2007) The involvement of apoptosis in melanoma vasculogenic mimicry. Mel Res 17:1–8CrossRef Vartanian A, Burova O, Stepanova E, Baryshnikov AYu, Lichinitser MR (2007) The involvement of apoptosis in melanoma vasculogenic mimicry. Mel Res 17:1–8CrossRef
21.
go back to reference Liu Z, Xiao M, Balint K, Smally K, Bradford P, Qiu R et al (2006) Notch signalling promotes primary melanoma progression by activating Mitogen-activated protein kinase/phosphatidylinosotol 3-kinase-Akt pathway and upregulate N-cadherin expression. Cancer Res 66:4182–4190PubMedCrossRef Liu Z, Xiao M, Balint K, Smally K, Bradford P, Qiu R et al (2006) Notch signalling promotes primary melanoma progression by activating Mitogen-activated protein kinase/phosphatidylinosotol 3-kinase-Akt pathway and upregulate N-cadherin expression. Cancer Res 66:4182–4190PubMedCrossRef
22.
go back to reference Kame T (2009) Novel insights into the differentiatial funcrions of Notch ligands in vascular formation. J Angiogeneisi Res 16:1–8 Kame T (2009) Novel insights into the differentiatial funcrions of Notch ligands in vascular formation. J Angiogeneisi Res 16:1–8
23.
go back to reference Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D et al (2009) Preclinical profile of a potent γ-secretase inhibitor targeting Notch signalling with in vivo efficacy and pharmacodynamic properties. Cancer Res 68(19):7672–7680CrossRef Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D et al (2009) Preclinical profile of a potent γ-secretase inhibitor targeting Notch signalling with in vivo efficacy and pharmacodynamic properties. Cancer Res 68(19):7672–7680CrossRef
24.
go back to reference Hess AR, Seftor EA, Seftor RE, Hendrix MJ (2003) Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63:4757–4762PubMed Hess AR, Seftor EA, Seftor RE, Hendrix MJ (2003) Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63:4757–4762PubMed
25.
go back to reference Vartanian A, Stepanova E, Grigorieva I, Solomko E, Baryshnikov A, Lichinitser M (2011) VEGFR1 and PKCalpha signalling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Mel Res 21(2):91–98CrossRef Vartanian A, Stepanova E, Grigorieva I, Solomko E, Baryshnikov A, Lichinitser M (2011) VEGFR1 and PKCalpha signalling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Mel Res 21(2):91–98CrossRef
26.
go back to reference Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J (2011) VEGFR1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71(4):1474–1485PubMedCrossRef Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J (2011) VEGFR1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71(4):1474–1485PubMedCrossRef
27.
go back to reference Helfrich E, Schadendorf D (2011) Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic resistance? Mol Oncol 5:137–149PubMedCrossRef Helfrich E, Schadendorf D (2011) Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic resistance? Mol Oncol 5:137–149PubMedCrossRef
28.
30.
go back to reference Yan M, Plowman GB (2007) Delta-like 4/Notch signalling and its theraupetic implications. Cancer Res 13(24):7243–7246 Yan M, Plowman GB (2007) Delta-like 4/Notch signalling and its theraupetic implications. Cancer Res 13(24):7243–7246
31.
go back to reference Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Hendrix MJ (2010) Regulation of the embryonic morphogen Nodal by Notch facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70(24):1034010350CrossRef Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Hendrix MJ (2010) Regulation of the embryonic morphogen Nodal by Notch facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70(24):1034010350CrossRef
32.
go back to reference Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231PubMedCrossRef Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231PubMedCrossRef
Metadata
Title
The involvement of Notch signaling in melanoma vasculogenic mimicry
Authors
Amalia Vartanian
Galina Gatsina
Irina Grigorieva
Elico Solomko
Vladislav Dombrovsky
Anatoly Baryshnikov
Eugenia Stepanova
Publication date
01-08-2013
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 3/2013
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-012-0190-9

Other articles of this Issue 3/2013

Clinical and Experimental Medicine 3/2013 Go to the issue